» Powikłania pogrypowe – immunologiczne zaburzenia i predyspozycje do wtórnych infekcji bakteryjnych. Addytywne efekty szczepionek

*Maria Kozioł-Montewka

Powikłania pogrypowe – immunologiczne zaburzenia i predyspozycje do wtórnych infekcji bakteryjnych. Addytywne efekty szczepionek

The post influenza complications – immunological disturbances and predisposition to the development of secondary bacterial infections. The additive effect of the vaccines

Katedra i Zakład Mikrobiologii Lekarskiej Uniwersytetu Medycznego w Lublinie
Kierownik Katedry i Zakładu: prof. dr hab. n. med. Maria Kozioł-Montewka

Summary

Key words:

Piśmiennictwo

1. Kuszewski K., Brydak L.B., Macha-a M. i wsp.: Grypa w 2003 roku. Przegl. Epidemiol. 2005; 59: 223-228. 2. Podewils L.J., Liedtke L.A., McDonald L.C. i wsp.: A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin. Infect. Dis. 2005; 40: 1693-1696. 3. Sethi S.: Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 2002; 57 (3): 56-61. 4. Heikkinen T., Chonmaitree T.: Increasing importance of viruses in acute otitis media. Ann. Med. 2000; 32 (3): 157-163. 5. Read R.C., Goodwin L., Parsons M.A. i wsp.: Coinfection with inflenza B wirus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture. Infect. Immun. 1999; 67 (6): 3082-3086. 6. Okabe N., Yamashita K., Taniguchi K. i wsp.: Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr. Int. 2000; 42 (2): 187-191. 7. Kawada J., Kimura H., Ito Y. i wsp.: Systemic cytokine responses in patients with influenza-associated encephalopathy. J. Infect. Dis. 2003; 188 (5): 690-698. 8. Irving W.L., James D.K., Stephenson T. i wsp.: Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG: Int. J. Obstet. Gynaecol. 2000; 107 (10): 1282-1289. 9. Wright P., Takei N., Rifkin L. i wsp.: Maternal influenza, obstetric complications, and schizophrenia. Am. J. Psychiatry 1995; 152 (12): 1714-1720. 10. Yoshino M., Suzuki S., Adachi K. i wsp.: High incidence of acute myositis with type A influenza virus infection in the elderly. Intern. Med. 2000; 39 (5): 431-432. 11. Agyeman P., Duppenthaler A., Heininger U. i wsp.: Influenza-associated myositis in children. Infection 2004; 32 (4): 199-203. 12. Greaves K., Oxford J.S., Price Ch.P. i wsp.: The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch. of Intern. Med. 2003; 163 (2): 165-168. 13. Nolte K.B., Alakija P., Oty G. i wsp.: Influenza A virus infection complicated by fatal myocarditis. Am. J. Forensic Med. Pathol. 2000; 21 (4): 375-379. 14. Irwin D.E., Weatherby L.B., Huang W.Y. i wsp.: Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv. Res. 2001; 1 (1): 8. 15. Machado C.M.: Influenza infections after hematopoietic stem cell transplantation. Clin. Infect. Dis. 2005; 41: 273-274. 16. Zeller V., Bricaire F.: Influenza pneumonia. Rev. Prat. 2003; 53 (13): 1442-1445. 17. Mohan S.S., Nair V., Cunha B.A.: Post-viral influenza Streptococcus pneumoniae in an intravenous drug abuser. Heart Lung 2005; 34 (3): 222-226. 18. van der Flier M., van Diujk N.B., Fluit A.C. i wsp.: Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin. Ned. Tijdschr. Geneeskd. 2003; 147 (22): 1076-1079. 19. Gonzalez B.E., Hulten K.G., Dishop M.K. i wsp.: Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 2005; 41: 583-590. 20. Morgan M.: Staphylococcus aureus, Panton-Valentine-leukocidin, and necrotising pneumonia. BMJ 2005; 331: 793-794. 21. van der Sluijs K.F., van Elden L.J.R., Nijhuis M. i wsp.: IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 2004; 172: 7603-7609. 22. Beadling C., Slifka M.K.: How do viral infections predispose patients to bacterial infections? Curr. Opin. Infect. Dis. 2004; 17: 185-191. 23. Nguyen K.B., Biron C.A.: Synergism for cytokine-mediated disease during concurrent endotoxin and viralchallenges: roles for NK and T cell IFN-g production. J. Immunol. 1999; 162: 5238-5246. 24. McCullers J., Webster R.: A mouse model of dual infection with influenza virus and Streptococcus pnemoniae. In: Osterhaus A., Cox N., Hampson A., editors. Options for the control of influenza IV. Amsterdam: Elsevier Science 2001: 601-607. 25. Peltola V.T., McCullers J.A.: Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr. Infect. Dis. J. 2004; 23 (1 Suppl): S87-97. 26. Peltola V.T., Murti K.G., McCullers J.A.: Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis. 2005; 192: 249-257. 27. Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J. 2008; 5:52-57. 28. Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, Iwanaga T, Aizawa H, Nagatake T, Oishi K.Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine. 2008;26:4284-9. 29. Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2008;153:764-70. 30. Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS. Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Womens Health (Larchmt). 2008; 17:1415-23. 31. Gupta RK, George R, Nguyen-Van-Tam JS.Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008; 14:1187-92.J Pediatr. 2008 Dec;153(6):764-70. 32. McCullers J.A., Rehg J.E.: Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 2002; 186 (3): 341-350. 33. Centers for Disease Control and Prevention. Update: influenza-associated deaths reported among children aged <18 years-United States, 2003-04 influenza season. MMWR Morb. Mortal Wkly. Rep. 2004; 52: 1254-1255. 34. McCullers J.A.: Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect. Dis. 2004; 190 (3): 519-526. 35. Abramson J.S., Lyles D.S., Heller K.A. i wsp.: Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza. Infect. Immun. 1982; 35: 350. 36. Julkunen I., Melen K., Nyqvist M. i wsp.: Inflammatory responses in influenza A virus infection. Vaccine 2000; 19 (Suppl. 1): S32-7. 37. Budowa i rola receptorów Toll-like. 38. Haynes L.M., Moore D.D., Kurt-Jones E.A. i wsp.: Involvement of Toll-like receptor 4 in innate immunity to Respiratory Syncytial Virus. J. Virol. 2001; 75 (22): 10730-10737. 39. Jackson D.C., Lau Y.F., Le T. i wsp.: A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 2004; 101 (43): 15440-15445. 40. Kochan P.: Zalecany sk-ad szczepionki przeciwko wirusowi grypy na sezon 2005-2006. Zakażenia 2005; 4: 89-92. 41. Heikkinen T., Silvennoinen H., Peltola V. i wsp.: Burden of influenza in children in the community. J. Infect. Dis. 2004; 190 (8): 1369-1373. 42. Sugaya N., Takeuchi Y.: Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin. Infect. Dis. 2005; 41: 939-947. 43. Pichichero M.E., Green J.L., Francis A.B. i wsp.: Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice. Pediatrics 2000; 105 (4 Pt 1): 753-759.

otrzymano/received: 2009-03-10
zaakceptowano/accepted: 2009-04-02

Adres/address:
*Maria Kozioł-Montewka
Katedra i Zakład Mikrobiologii Lekarskiej, Akademia Medyczna
ul. Chodźki 1, 20-093 Lublin
tel.fax: (0-81) 742-37-81
e-mail: koziolm@yahoo.com

Pełna wersja artykułu Powikłania pogrypowe – immunologiczne zaburzenia i predyspozycje do wtórnych infekcji bakteryjnych. Addytywne efekty szczepionek dostępna w Czytelni Medycznej Borgis.

Copyright © Wydawnictwo Medyczne Borgis Sp. z o.o. 2007-2013
Chcesz być na bieżąco? Polub nas na Facebooku: strona Wydawnictwa na Facebooku